'Hiv 2' diaporamas de présentation

HIV Diagnosis, Acute Infection and Superinfection

HIV Diagnosis, Acute Infection and Superinfection. Don Kurtyka, ARNP, MS, MBA University of South Florida College of Medicine Tampa General Hospital Hillsborough County Health Department. Objectives. Discuss the diagnosis of HIV and available tests

771 views • 66 slides

New Approaches for Infectious Diseases Testing in Clinical Laboratories

New Approaches for Infectious Diseases Testing in Clinical Laboratories. William M. Janda , Ph.D., D(ABMM) Professor Emeritus of Pathology University of Illinois College of Medicine University of Illinois at Chicago Director, Clinical Microbiology Laboratory

1.04k views • 58 slides

MICR 420

MICR 420. Emerging and Re-Emerging Infectious Diseases Lecture 11: HIV Dr. Nancy McQueen & Dr. Edith Porter. Overview. Brief history Nomenclature Morphology and nature of the genome Viral replication cycle Pathogenesis and clinical symptoms Diagnosis Treatment Prevention Threat.

827 views • 57 slides

2014: HIV, HCV, and HBV Update

2014: HIV, HCV, and HBV Update. David Spach, MD Professor of Medicine, Division of Infectious Diseases University of Washington. Last Updated: June 12 , 2013. Chronic Viral Diseases and Mortality in United States.

691 views • 54 slides

895 views • 47 slides

Prof. dr Biljana Koci ?

692 views • 36 slides

Standardization – CBER update

Standardization – CBER update. June 12, 2007 XX SoGAT Indira Hewlett, Ph.D. Chief, Lab. of Molecular Virology DETTD/CBER/FDA. Current status of NAT in United States. Donor screening NAT assays licensed for HIV-1, HBV, HCV, WNV

510 views • 35 slides

Simulating the origin of HIV-1 group M in Kinshasa: why did the epidemic emerge when it did?

398 views • 31 slides

Health Psychology

425 views • 29 slides

HIV variants and US licensed assays

HIV variants and US licensed assays. Indira Hewlett, Ph.D Chief, Lab. of Molecular Virology CBER/FDA XIX SOGAT, 2006. HIV genetic diversity: subtypes and homology. 70%. A. B. C. J. HIV-2. HIV-1 M. D. I. 50%. E. A. B. H. F. 70%. G. 75% mac/SM. 60%. HIV-1 O. HIV-1 N.

379 views • 24 slides

Robert A. Myers Ph.D.

Identifying HIV-2 Infections Using Differential Serological Assays HIV-1 (gp41)/HIV-2(gp36) (Select HIV or MultiSpot) by Testing HIV EIA Reactive Specimens Unconfirmed HIV-1 Antibody by HIV-1 Western Blot. Robert A. Myers Ph.D. Presentation Overview.

364 views • 23 slides

Diagnosis and Management of HIV-2 in Adults hivguidelines

Diagnosis and Management of HIV-2 in Adults www.hivguidelines.org. Purpose of this Guideline. Inform clinicians about when to suspect and how to diagnose and manage the care of adults with HIV-2.

276 views • 21 slides

New strategies for HIV diagnostic algorithms

Multi-test strategies for the determination of HIV serostatus without the use of Western immunoblotting. New strategies for HIV diagnostic algorithms. Jane Feldman, Susan Wells, Michele Owen, and Tim Granade. Current HIV testing algorithm CDC/APHL -- 1993. Screen by EIA

366 views • 19 slides

HIV-1/HIV-2 PLUS O

359 views • 19 slides

Quantification of SIV RNA and evaluation of infectivity

Quantification of SIV RNA and evaluation of infectivity. Neil Berry Division of Retrovirology NIBSC, UK. Transfer of Simian Immunodeficiency viruses. Simian immunodeficiency viruses (SIV) are highly prevalent in non-human primates with 30+ species infected with a diverse range of SIVs

238 views • 15 slides

SPECIAL CONSIDERATIONS

SPECIAL CONSIDERATIONS. August 2012. Acute HIV Infection (1). Primary or acute HIV infection in pregnancy or during breast-feeding is associated with increased risk of transmission. Counsel all pregnant or breast-feeding women about prevention of HIV. Reinforce importance of using condoms.

262 views • 15 slides

NEW YORK STATE DEPARTMENT OF HEALTH WADSWORTH CENTER ALBANY, NY

Evaluation of a Proposed Testing Strategy for Laboratory-based Testing Using an HIV-1/2 Discriminatory Assay for HIV: Strategy 5 Data Needs. R. Boromisa, J. Schwendemann, M. Parker, T. Sullivan. NEW YORK STATE DEPARTMENT OF HEALTH WADSWORTH CENTER ALBANY, NY.

281 views • 12 slides

Background

202 views • 6 slides

Phylogenic subgroup of HIV-2

Phylogenic subgroup of HIV-2 This phylogenic tree demonstrates the multiple subgroups within the HIV-2 viral family. Horizontal branch lengths represent the relative genetic distances between each group. HIV-2 predominantly comes from western Africa Within each subgroup of

173 views • 5 slides

ANRS Satellite HIV-2: a model of attenuated HIV infection

192 views • 4 slides